These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 28816139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
    Shin YS, Park JH, Yoon SM, Kim JC, Yu CS, Lim SB, Park IJ, Kim TW, Hong YS, Kim KP, Choi EK, Ahn SD, Lee SW, Kim JH.
    Int J Radiat Oncol Biol Phys; 2018 Jul 01; 101(3):630-639. PubMed ID: 29678529
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Local excision for ypT2 rectal cancer following preoperative chemoradiation therapy: it should not be justified.
    Yang KM, Lim SB, Lee JL, Kim CW, Yoon YS, Park IJ, Yu CS, Kim JC.
    Int J Colorectal Dis; 2018 Apr 01; 33(4):487-491. PubMed ID: 29468352
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E, Ozkok S, Tekin M, Yoldas T, Caliskan C, Kose T, Karabulut B, Sezak M, Elmas N, Ozutemiz O.
    World J Surg Oncol; 2017 Nov 22; 15(1):205. PubMed ID: 29166925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Local excision of T1 and T2 rectal cancer: proceed with caution.
    Elmessiry MM, Van Koughnett JA, Maya A, DaSilva G, Wexner SD, Bejarano P, Berho M.
    Colorectal Dis; 2014 Sep 22; 16(9):703-9. PubMed ID: 24787457
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MRI-defined T3, clear mesorectal fascia mid-low rectal cancer: is neoadjuvant treatment necessary?
    Zeng Z, Li Z, Luo S, Huang L, Liang Z, Zheng X, Li W, Xiong L, Liu H, Kang L.
    J Gastroenterol Hepatol; 2024 May 22; 39(5):858-867. PubMed ID: 38225773
    [Abstract] [Full Text] [Related]

  • 12. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
    Lee JH, Jang HS, Kim JG, Cho HM, Shim BY, Oh ST, Yoon SC, Kim YS, Choi BO, Kim SH.
    Ann Surg Oncol; 2012 Apr 22; 19(4):1213-21. PubMed ID: 21935746
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH, Zhou CJ, Zhang S, Wang QX, Xiao WW, Ding PR, Chen G, Pan ZZ, Zeng ZF, Gao YH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar 25; 23(3):266-273. PubMed ID: 32192306
    [Abstract] [Full Text] [Related]

  • 15. The impact of robotic total mesorectal excision on survival of patients with rectal cancer-a propensity matched analysis.
    Tejedor P, Sagias F, Flashman K, Lee YH, Naqvi S, Kandala N, Khan J.
    Int J Colorectal Dis; 2019 Dec 25; 34(12):2081-2089. PubMed ID: 31712874
    [Abstract] [Full Text] [Related]

  • 16. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial.
    Wang F, Fan W, Peng J, Lu Z, Pan Z, Li L, Gao Y, Li H, Chen G, Wu X, Ding P, Zeng Z, Wan D.
    Cancer Commun (Lond); 2018 Dec 20; 38(1):73. PubMed ID: 30572939
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
    Sun XY, Cai SH, Xu L, Luo D, Qiu HZ, Wu B, Lin GL, Lu JY, Zhang GN, Xiao Y.
    Asia Pac J Clin Oncol; 2020 Jun 20; 16(3):142-149. PubMed ID: 32031326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparing neoadjuvant therapy followed by local excision to total mesorectal excision in the treatment of early stage rectal cancer: a systematic review and meta-analysis of randomised clinical trials.
    Lynch P, Ryan OK, Donnelly M, Ryan ÉJ, Davey MG, Reynolds IS, Creavin B, Hanly A, Kennelly R, Martin ST, Winter DC.
    Int J Colorectal Dis; 2023 Nov 04; 38(1):263. PubMed ID: 37924372
    [Abstract] [Full Text] [Related]

  • 20. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T.
    Ann Surg; 2007 Nov 04; 246(5):754-62. PubMed ID: 17968166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.